Near-Term, Can This Stock Move the Needle: Marrone Bio Innovations, Inc. (NASDAQ:MBII)

Seasoned investors are often on the lookout for a value name with solid upside.  Recently attention has been given to shares of Marrone Bio Innovations, Inc. (NASDAQ:MBII) as the stock recently touched $1.59, a 2.58% move from the most recent open.

Occasionally, a certain stock may perform much higher than expectations, and it may become a much greater percentage of the portfolio. This is typically a good thing, but it may require some decisions on what to do with the portfolio allocations. If one stock is making up a high percentage of the total, it may create the risk of higher than normal average losses if the shares take an unforeseen dive lower. Even if the stock has the potential to go much higher, it can be tricky to know when to sell and find other stocks that might be a better value. Selling a winner might leave the average investor frustrated if the stock goes higher, but there may be nothing wrong with taking profits and not leaving gains on the table. As we move into the second half of the year, investors may want to compare first half gains with goals that were established at the beginning of the year. This may help narrow in on what needs to be done in order to stay in the green for the rest of the year and beyond. Setting portfolio goals may be a good way to stay the course when things get a little hairy in the markets.

Based on recent analysis, Marrone Bio Innovations, Inc. (NASDAQ:MBII) shares have been seen trading -8.62% off of the 50-day peak and 15.22% away from the 50-day bottom. In terms of the stock price in relation to its moving averages, company shares are 4.02% away from the 20-day moving average and 2.30% off of the 50-day average. If we take a longer approach, shares have been trading -4.07% away from the 200-day moving average.

Investors will most likely be looking ahead to the next round of company earnings reports. As the reports come in, all eyes will be on the companies that post wide margin earnings beats or misses. Many investors will be closely tracking which way analyst estimates are being adjusted right before earnings. This may provide some insight on how good or bad the numbers for the quarter are likely to be. Investors might want to take a look at their holdings after the earnings reports to make sure that nothing extremely odd is occurring after crunching the numbers.

Over the last year, Marrone Bio Innovations, Inc. (NASDAQ:MBII)’s stock has performed
-18.46%. For the last six months, the stock has performed -8.09%. From the start of the calendar year, shares have been 8.16%. Zooming in closer, company stock has been 14.39% for the quarter, -5.36% over the past month, and 11.97% over the past week.

When examining stocks, investors might be doing top down research. Top down analysis begins with looking at certain macro-economic factors. This may involve focusing in on the bigger picture and going all the way down to specific stocks. Starting at the top, investors may check on the global economic environment, overall market trends, and sector trends. Investors may choose to start doing research the other way around. This may involve first looking at the fundamentals for particular stocks in order to gauge the strength from a company standpoint. Many investors will scope out all the different investing aspects as to not leave any information uncovered.

Disclaimer: The views, opinions, and information expressed in this article are those of the authors and do not necessarily reflect the official policy or position of any company stakeholders, financial professionals, or analysts. Examples of analysis performed within this article are only examples. They should not be utilized to make stock portfolio or financial decisions as they are based only on limited and open source information. Assumptions made within the analysis are not reflective of the position of any analysts or financial professionals.